{"transactions":[{"id":713517,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2026-07-07T21:26:03.000Z","date":"2026-07-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":3062,"price":4.99,"value":15279.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported on this Form 4 represents shares disposed of by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The disposition is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":411400,"source":{"system":"sec-edgar","filing":"0000912282-26-000929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228226000929/form4.xml","form_type":"4"}},{"id":824071,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2026-03-31T20:59:51.000Z","date":"2026-03-30","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.85,"value":28500.0,"ownership":{"direct":true},"balance_after":414462,"source":{"system":"sec-edgar","filing":"0000912282-26-000533","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228226000533/form4.xml","form_type":"4"}},{"id":861186,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2026-03-04T23:16:14.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":11438,"price":2.99,"value":34199.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported on this Form 4 represents shares disposed of by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The disposition is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.98 to $3.07, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":404462,"source":{"system":"sec-edgar","filing":"0000912282-26-000411","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228226000411/form4.xml","form_type":"4"}},{"id":969210,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2025-12-16T00:35:57.000Z","date":"2025-12-15","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.79,"value":4475.0,"ownership":{"direct":false,"nature":"Held by minor child #3"},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0000912282-25-001424","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228225001424/form4.xml","form_type":"4"}},{"id":969209,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2025-12-16T00:35:57.000Z","date":"2025-12-15","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.785,"value":4462.5,"ownership":{"direct":false,"nature":"Held by minor child #2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.78 to $1.79, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0000912282-25-001424","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228225001424/form4.xml","form_type":"4"}},{"id":969208,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2025-12-16T00:35:57.000Z","date":"2025-12-15","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":1.766,"value":70640.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.65 to $1.81, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":415900,"source":{"system":"sec-edgar","filing":"0000912282-25-001424","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228225001424/form4.xml","form_type":"4"}},{"id":991207,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-11-21T22:31:29.000Z","date":"2025-11-19","kind":"grant","planned":false,"acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest 1/36th monthly beginning on December 19, 2025."}],"balance_after":63000,"derivative":{"exercise_price":10.16,"expiration_date":"2035-11-19","underlying":"Common Shares","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0000912282-25-001292","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228225001292/form4.xml","form_type":"4"}},{"id":991206,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2025-11-21T22:31:29.000Z","date":"2025-11-19","kind":"grant","planned":false,"acquired":true,"shares":107000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units which vest annually over a three-year period with the first RSUs vesting on December 1, 2026."}],"balance_after":375900,"source":{"system":"sec-edgar","filing":"0000912282-25-001292","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228225001292/form4.xml","form_type":"4"}},{"id":1102572,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2025-06-24T16:41:19.000Z","date":"2025-06-24","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.05,"value":20250.0,"ownership":{"direct":true},"balance_after":268900,"source":{"system":"sec-edgar","filing":"0000912282-25-000706","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228225000706/form4.xml","form_type":"4"}},{"id":1113188,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-13T01:29:48.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest as follows:  1/36th monthly beginning on July 10, 2025."}],"balance_after":15000,"derivative":{"exercise_price":4.39,"expiration_date":"2035-06-10","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000912282-25-000661","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228225000661/form4.xml","form_type":"4"}},{"id":1113187,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2025-06-13T01:29:48.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units which vest as follows:  1/3 on July 1, 2026; 1/3 on July 1, 2027; and 1/3 on July 1, 2028."}],"balance_after":263900,"source":{"system":"sec-edgar","filing":"0000912282-25-000661","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228225000661/form4.xml","form_type":"4"}},{"id":1188767,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2025-03-28T12:40:13.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.88,"value":28800.0,"ownership":{"direct":false,"nature":"Minor child #1"},"balance_after":23000,"source":{"system":"sec-edgar","filing":"0000912282-25-000339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228225000339/form4.xml","form_type":"4"}},{"id":1188766,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2025-03-28T12:40:13.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.89,"value":28900.0,"ownership":{"direct":true},"balance_after":237900,"source":{"system":"sec-edgar","filing":"0000912282-25-000339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228225000339/form4.xml","form_type":"4"}},{"id":1259580,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-20T02:29:02.000Z","date":"2025-02-16","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest as follows:  1/36th monthly beginning on March 16, 2025."}],"balance_after":45000,"derivative":{"exercise_price":4.61,"expiration_date":"2035-02-16","underlying":"Common Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000912282-25-000180","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228225000180/form4.xml","form_type":"4"}},{"id":1259579,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2025-02-20T02:29:02.000Z","date":"2025-02-16","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units which vest as follows:  1/3 on March 1, 2026; 1/3 on March 1, 2027; and 1/3 on March 1, 2028."}],"balance_after":227900,"source":{"system":"sec-edgar","filing":"0000912282-25-000180","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228225000180/form4.xml","form_type":"4"}},{"id":1326515,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2024-12-18T23:01:12.000Z","date":"2024-12-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.29,"value":42900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported above is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $4.275 and $4.33, inclusive.  The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":150900,"source":{"system":"sec-edgar","filing":"0000912282-24-000908","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000908/form4.xml","form_type":"4"}},{"id":1333699,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2024-12-12T21:54:50.000Z","date":"2024-12-12","kind":"purchase","planned":false,"acquired":true,"shares":9000,"price":4.6,"value":41400.0,"ownership":{"direct":true},"balance_after":140900,"source":{"system":"sec-edgar","filing":"0000912282-24-000884","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000884/form4.xml","form_type":"4"}},{"id":1337055,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2024-12-10T14:11:35.000Z","date":"2025-12-09","kind":"purchase","planned":false,"acquired":true,"shares":10549,"price":5.04,"value":53166.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported above is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $4.985 to $5.0559, inclusive.  The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":131900,"source":{"system":"sec-edgar","filing":"0000912282-24-000863","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000863/form4.xml","form_type":"4"}},{"id":1400062,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-09-24T17:03:44.000Z","date":"2024-09-23","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows:  One-fourth (1/4) on the one-year anniversary of the grant date and one thirty-sixth (1/36) of the remaining options shall vest on the same day of each month thereafter until the option is 100% vested.  The unvested portion of the option will not be exercisable on or after the Reporting Person's termination of Continuous Service subject to the terms of the Reporting Person's employment agreement."}],"balance_after":100000,"derivative":{"exercise_price":4.79,"expiration_date":"2034-09-23","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000912282-24-000673","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000673/form4.xml","form_type":"4"}},{"id":1478845,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2024-06-14T16:06:37.000Z","date":"2024-06-14","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":4.0392,"value":161568.0,"ownership":{"direct":false,"nature":"Held by PoC Capital, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported above is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $3.85 to $4.25, inclusive.  The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"PoC Capital, LLC is a California limited liability company managed by the reporting person.  The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0000912282-24-000494","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000494/form4.xml","form_type":"4"}},{"id":1496575,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2024-05-31T20:05:38.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":451,"price":3.5,"value":1578.5,"ownership":{"direct":true},"balance_after":121351,"source":{"system":"sec-edgar","filing":"0000912282-24-000472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000472/form4.xml","form_type":"4"}},{"id":1500238,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2024-05-28T18:48:31.000Z","date":"2024-05-24","kind":"purchase","planned":false,"acquired":true,"shares":2942,"price":3.23,"value":9502.66,"ownership":{"direct":false,"nature":"Held by minor child #1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported above is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $3.21 to $3.23, inclusive.  The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0000912282-24-000460","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000460/form4.xml","form_type":"4"}},{"id":1500237,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2024-05-28T18:48:31.000Z","date":"2024-05-23","kind":"purchase","planned":false,"acquired":true,"shares":58,"price":2.85,"value":165.3,"ownership":{"direct":false,"nature":"Held by minor child #1"},"balance_after":10058,"source":{"system":"sec-edgar","filing":"0000912282-24-000460","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000460/form4.xml","form_type":"4"}},{"id":1568295,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2024-03-19T13:17:42.000Z","date":"2024-03-15","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.6915,"value":33830.0,"ownership":{"direct":false,"nature":"Held by spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported above is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.69 to $1.70, inclusive.  The reporting person undertakes to provide to Rezolute, Inc., any securityholder of Rezolute, Inc. or the staff of the Securities an Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000912282-24-000274","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000274/form4.xml","form_type":"4"}},{"id":1586491,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2024-03-08T17:37:44.000Z","date":"2024-03-08","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.9269,"value":96345.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported above is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.83 to $1.95, inclusive.  The reporting person undertakes to provide to Rezolute, Inc., any securityholder of Rezolute, Inc. or the staff of the Securities an Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":120900,"source":{"system":"sec-edgar","filing":"0000912282-24-000232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000232/form4.xml","form_type":"4"}},{"id":1633379,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2024-02-20T12:01:49.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":1.37,"value":6165.0,"ownership":{"direct":false,"nature":"Held by minor child #3"},"balance_after":4500,"source":{"system":"sec-edgar","filing":"0000912282-24-000163","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000163/form4.xml","form_type":"4"}},{"id":1633378,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2024-02-20T12:01:49.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":1.37,"value":6165.0,"ownership":{"direct":false,"nature":"Held by minor child #2"},"balance_after":4500,"source":{"system":"sec-edgar","filing":"0000912282-24-000163","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000163/form4.xml","form_type":"4"}},{"id":1633377,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Common Shares","published_at":"2024-02-20T12:01:49.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":41900,"price":1.2986,"value":54411.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.17 to $1.39, inclusive. The reporting person undertakes to provide to Rezolute, Inc.., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":70900,"source":{"system":"sec-edgar","filing":"0000912282-24-000163","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000163/form4.xml","form_type":"4"}},{"id":1670839,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"officer":true,"officer_title":"CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-25T17:47:59.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 23, 2024, and shall vest as follows:  One-fourth (1/4) on the one-year anniversary of the grant date and one thirty-sixth (1/36) of the remaining options shall vest on the same day of each month thereafter until the option is 100% vested.  The unvested portion of the option will not be exercisable on or after the Reporting Person's termination of Continuous Service subject to the terms of the Reporting Person's employment agreement."}],"balance_after":275000,"derivative":{"exercise_price":1.02,"expiration_date":"2029-01-23","underlying":"Common Shares","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0000912282-24-000089","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091228224000089/form4.xml","form_type":"4"}},{"id":2688779,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO Specialty Renal Products"}}],"security":"Common Stock","published_at":"2021-06-01T21:39:58.000Z","date":"2021-05-27","kind":"tax_withholding","acquired":false,"shares":349,"price":2.7,"value":942.3,"ownership":{"direct":false,"nature":"By UTMA #2"},"balance_after":8669,"source":{"system":"sec-edgar","filing":"0000914190-21-000169","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419021000169/edgar.xml","form_type":"4/A","original_submission_date":"2021-05-25"}},{"id":2688778,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO Specialty Renal Products"}}],"security":"Common Stock","published_at":"2021-06-01T21:39:58.000Z","date":"2021-05-27","kind":"tax_withholding","acquired":false,"shares":349,"price":2.7,"value":942.3,"ownership":{"direct":false,"nature":"By UTMA #1"},"balance_after":8947,"source":{"system":"sec-edgar","filing":"0000914190-21-000169","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419021000169/edgar.xml","form_type":"4/A","original_submission_date":"2021-05-25"}},{"id":2696812,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO of Specialty Renal Product"}}],"security":"Common Stock Warrants (Right to Buy)","published_at":"2021-05-25T19:40:39.000Z","date":"2021-05-24","kind":"other","acquired":false,"shares":1111,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By UTMA #2"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Previous filings mistakenly reflected this amount as 1,112 shares; the correct amount after appropriate rounding adjustments is 1,111 shares, as reflected above."}],"balance_after":0,"derivative":{"exercise_price":2.7,"exercise_date":"2016-06-03","expiration_date":"2021-06-03","underlying":"Common Stock","underlying_shares":1111},"source":{"system":"sec-edgar","filing":"0000914190-21-000162","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419021000162/edgar.xml","form_type":"4"}},{"id":2696811,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO of Specialty Renal Product"}}],"security":"Common Stock Warrants (Right to Buy)","published_at":"2021-05-25T19:40:39.000Z","date":"2021-05-24","kind":"other","acquired":false,"shares":1111,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By UTMA #1"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"Previous filings mistakenly reflected this amount as 1,112 shares; the correct amount after appropriate rounding adjustments is 1,111 shares, as reflected above."}],"balance_after":0,"derivative":{"exercise_price":2.7,"exercise_date":"2016-06-03","expiration_date":"2021-06-03","underlying":"Common Stock","underlying_shares":1111},"source":{"system":"sec-edgar","filing":"0000914190-21-000162","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419021000162/edgar.xml","form_type":"4"}},{"id":2696810,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO of Specialty Renal Product"}}],"security":"Common Stock","published_at":"2021-05-25T19:40:39.000Z","date":"2021-05-24","kind":"other","acquired":true,"shares":1111,"price":2.7,"value":2999.7,"ownership":{"direct":false,"nature":"By UTMA #2"},"balance_after":9018,"source":{"system":"sec-edgar","filing":"0000914190-21-000162","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419021000162/edgar.xml","form_type":"4"}},{"id":2696809,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO of Specialty Renal Product"}}],"security":"Common Stock","published_at":"2021-05-25T19:40:39.000Z","date":"2021-05-24","kind":"other","acquired":true,"shares":1111,"price":2.7,"value":2999.7,"ownership":{"direct":false,"nature":"By UTMA #1"},"balance_after":9296,"source":{"system":"sec-edgar","filing":"0000914190-21-000162","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419021000162/edgar.xml","form_type":"4"}},{"id":3213380,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-12T21:02:08.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":2500,"price":6.65,"value":16625.0,"ownership":{"direct":true},"balance_after":134215,"source":{"system":"sec-edgar","filing":"0000914190-20-000113","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419020000113/edgar.xml","form_type":"4"}},{"id":3224386,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-03-05T22:18:04.000Z","date":"2020-03-05","kind":"purchase","acquired":true,"shares":2500,"price":8.4436,"value":21109.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.40 to $8.4567. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":131715,"source":{"system":"sec-edgar","filing":"0000914190-20-000107","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419020000107/edgar.xml","form_type":"4"}},{"id":3288481,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-05T22:13:55.000Z","date":"2020-02-01","kind":"grant","acquired":true,"shares":97076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On 4/15/15, the Reporting Person was granted an option to purchase up to 242,690 shares of common stock of the Company. Options to purchase 84,941 shares vest quarterly in 16 equal amounts commencing on 6/30/15; options to purchase 36,404 shares vested upon the approval of the listing of the Company's common stock on the Nasdaq Stock Market; and options to purchase 121,345 shares will vest, if ever, upon the Company's achievement of certain annual revenue milestones as specified in that certain Employment Agreement dated 4/15/15 between the Reporting Person and the Company. The Company achieved the $3,000,000 annual revenue milestone in fiscal year 2017 and options to purchase 24,269 shares vested on 2/1/18.  The Company achieved both the $6,000,000 and $10,000,000 annual revenue milestones in fiscal year 2019 and 97,076 shares vested on 2/1/20."}],"balance_after":242690,"derivative":{"exercise_price":5.4,"expiration_date":"2025-04-15","underlying":"Common Stock","underlying_shares":97076},"source":{"system":"sec-edgar","filing":"0000914190-20-000041","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419020000041/edgar.xml","form_type":"4"}},{"id":3336670,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-18T22:14:16.000Z","date":"2019-12-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On 12/16/19, the Reporting Person was granted an option to purchase 20,000 shares of common stock of the Company.  Options to purchase 5,000 shares vest on 12/16/20 and options to purchase 15,000 shares vest quarterly in 12 equal amounts commencing on 3/16/21."}],"balance_after":20000,"derivative":{"exercise_price":8.57,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000914190-19-000509","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419019000509/edgar.xml","form_type":"4"}},{"id":3336669,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-12-18T22:14:16.000Z","date":"2019-12-16","kind":"grant","acquired":true,"shares":9282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 16, 2019, the Company granted 9,282 shares of restricted stock (the \"Restricted Stock\") to the Reporting Person in lieu of a cash bonus. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date."}],"balance_after":129215,"source":{"system":"sec-edgar","filing":"0000914190-19-000509","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419019000509/edgar.xml","form_type":"4"}},{"id":3368052,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-18T17:12:32.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":1000,"price":8.35,"value":8350.0,"ownership":{"direct":true},"balance_after":119933,"source":{"system":"sec-edgar","filing":"0000914190-19-000416","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419019000416/edgar.xml","form_type":"4"}},{"id":3431059,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-22T20:09:38.000Z","date":"2019-08-22","kind":"purchase","acquired":true,"shares":2000,"price":6.9227,"value":13845.4,"ownership":{"direct":true},"balance_after":118933,"source":{"system":"sec-edgar","filing":"0000914190-19-000336","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419019000336/edgar.xml","form_type":"4"}},{"id":3439860,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-13T22:09:35.000Z","date":"2019-08-09","kind":"grant","acquired":true,"shares":36404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On 4/15/15, the Reporting Person was granted an option to purchase up to 242,690 shares of common stock of the Company. Options to purchase 84,941 shares vest quarterly in 16 equal amounts commencing on 6/30/15; options to purchase 36,404 shares vested upon the approval of the listing of the Company's common stock on the Nasdaq Stock Market; and options to purchase 121,345 shares will vest, if ever, upon the Company's achievement of certain annual revenue milestones as specified in that certain Employment Agreement dated 4/15/15 between the Reporting Person and the Company. The Company achieved the $3,000,000 annual revenue milestone in fiscal year 2017 and options to purchase 24,269 shares vested on 2/1/18."}],"balance_after":145614,"derivative":{"exercise_price":5.4,"expiration_date":"2025-04-15","underlying":"Common Stock","underlying_shares":36404},"source":{"system":"sec-edgar","filing":"0000914190-19-000294","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419019000294/edgar.xml","form_type":"4"}},{"id":3489440,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-06-14T16:34:13.000Z","date":"2019-06-14","kind":"purchase","acquired":true,"shares":8000,"price":0.6037,"value":4829.6,"ownership":{"direct":false,"nature":"By UTMA #4"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5925 to $0.6085. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0000914190-19-000212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419019000212/edgar.xml","form_type":"4"}},{"id":3489439,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-06-14T16:34:13.000Z","date":"2019-06-14","kind":"purchase","acquired":true,"shares":8000,"price":0.6094,"value":4875.2,"ownership":{"direct":false,"nature":"By UTMA #3"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.605 to $0.61. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0000914190-19-000212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419019000212/edgar.xml","form_type":"4"}},{"id":3489438,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-06-14T16:34:13.000Z","date":"2019-06-14","kind":"purchase","acquired":true,"shares":8000,"price":0.59,"value":4720.0,"ownership":{"direct":false,"nature":"By UTMA #2"},"balance_after":71166,"source":{"system":"sec-edgar","filing":"0000914190-19-000212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419019000212/edgar.xml","form_type":"4"}},{"id":3489437,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-06-14T16:34:13.000Z","date":"2019-06-14","kind":"purchase","acquired":true,"shares":8000,"price":0.5816,"value":4652.8,"ownership":{"direct":false,"nature":"By UTMA #1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.521 to $0.59. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":73666,"source":{"system":"sec-edgar","filing":"0000914190-19-000212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419019000212/edgar.xml","form_type":"4"}},{"id":3489436,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-06-14T16:34:13.000Z","date":"2019-06-14","kind":"purchase","acquired":true,"shares":11172,"price":0.5982,"value":6683.0904,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.59 to $0.60. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 108,296 shares of restricted stock that vest on 6/14/19."}],"balance_after":1052426,"source":{"system":"sec-edgar","filing":"0000914190-19-000212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419019000212/edgar.xml","form_type":"4"}},{"id":3726639,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-12-18T22:34:58.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":108296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2018, the Company granted 108,296 shares of restricted stock (the \"Restricted Stock\") to the Reporting Person in lieu of a cash bonus. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date."}],"balance_after":1001254,"source":{"system":"sec-edgar","filing":"0000914190-18-000571","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419018000571/edgar.xml","form_type":"4"}},{"id":3934616,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock Warrants (Right to Buy)","published_at":"2018-05-14T11:27:25.000Z","date":"2018-05-14","kind":"other","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By PoC Capital, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a managing director of the LLC that owns the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.3,"exercise_date":"2016-06-03","expiration_date":"2021-06-03","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000914190-18-000195","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419018000195/edgar.xml","form_type":"4"}},{"id":3934615,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-14T11:27:25.000Z","date":"2018-05-14","kind":"other","acquired":true,"shares":40000,"price":0.3,"value":12000.0,"ownership":{"direct":false,"nature":"By PoC Capital, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a managing director of the LLC that owns the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":95000,"source":{"system":"sec-edgar","filing":"0000914190-18-000195","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419018000195/edgar.xml","form_type":"4"}},{"id":3964680,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-04-12T20:12:50.000Z","date":"2018-04-10","kind":"purchase","acquired":true,"shares":12000,"price":0.45,"value":5400.0,"ownership":{"direct":false,"nature":"By UTMA #2"},"balance_after":63166,"source":{"system":"sec-edgar","filing":"0000914190-18-000139","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419018000139/edgar.xml","form_type":"4"}},{"id":3964679,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-04-12T20:12:50.000Z","date":"2018-04-10","kind":"purchase","acquired":true,"shares":12000,"price":0.45,"value":5400.0,"ownership":{"direct":false,"nature":"By UTMA #1"},"balance_after":65666,"source":{"system":"sec-edgar","filing":"0000914190-18-000139","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419018000139/edgar.xml","form_type":"4"}},{"id":3964678,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-04-12T20:12:50.000Z","date":"2018-04-10","kind":"purchase","acquired":true,"shares":55000,"price":0.45,"value":24750.0,"ownership":{"direct":false,"nature":"By PoC Capital, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a managing director of the LLC that owns the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."}],"balance_after":55000,"source":{"system":"sec-edgar","filing":"0000914190-18-000139","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419018000139/edgar.xml","form_type":"4"}},{"id":4040123,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-22T21:05:45.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":218419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On 4/15/2015, the Reporting Person was granted an option to purchase up to 2,184,193 shares of common stock of the Company. 35% of the shares subject to the option (relating to a total of 764,468 shares) vest quarterly in 16 equal amounts, commencing on 6/30/2015.  15% of the shares subject to the option will vest, if ever, upon the listing of the Company's common stock on NASDAQ, NYSE, or such other exchange as the Board may later determine.  The remaining 50% of the shares subject to the option will vest, if ever, upon the Company's achievement of certain annual revenue milestones as specified in that certain Employment Agreement dated 4/15/2015 between the Reporting Person and the Company. The Company achieved the $3,000,000 annual revenue milestone in fiscal year 2017 and 218,419 options vested on 2/1/18."}],"balance_after":982887,"derivative":{"exercise_price":0.6,"expiration_date":"2025-04-15","underlying":"Common Stock","underlying_shares":218419},"source":{"system":"sec-edgar","filing":"0000914190-18-000057","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419018000057/edgar.xml","form_type":"4"}},{"id":4122384,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-22T16:29:34.000Z","date":"2017-12-20","kind":"grant","acquired":true,"shares":837125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On 12/20/17, the Reporting Person was granted an option to purchase 837,125 shares of common stock of the Company.  25% of the shares subject to the option (relating to a total of 209,282 shares) vest on 12/20/18 and the remaining 75% of the shares subject to the option (relating to a total of 627,843 shares) vest quarterly in 12 equal amounts, commencing on 3/20/19."}],"balance_after":837125,"derivative":{"exercise_price":0.4999,"expiration_date":"2027-12-20","underlying":"Common Stock","underlying_shares":837125},"source":{"system":"sec-edgar","filing":"0000914190-17-000387","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000387/edgar.xml","form_type":"4"}},{"id":4122383,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-12-22T16:29:34.000Z","date":"2017-12-20","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 20, 2017, the Company granted 180,000 shares of restricted stock (the \"Restricted Stock\") to the Reporting Person in lieu of a cash bonus. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date."}],"balance_after":892958,"source":{"system":"sec-edgar","filing":"0000914190-17-000387","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000387/edgar.xml","form_type":"4"}},{"id":4215872,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-09-06T21:13:30.000Z","date":"2017-09-06","kind":"purchase","acquired":true,"shares":28000,"price":0.2435,"value":6818.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.23 to $0.25 inclusive. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 17,756 shares of restricted stock that vest on September 30, 2017."}],"balance_after":712958,"source":{"system":"sec-edgar","filing":"0000914190-17-000277","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000277/edgar.xml","form_type":"4"}},{"id":4215871,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-09-06T21:13:30.000Z","date":"2017-09-05","kind":"purchase","acquired":true,"shares":1580,"price":0.235,"value":371.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 17,756 shares of restricted stock that vest on September 30, 2017."}],"balance_after":684958,"source":{"system":"sec-edgar","filing":"0000914190-17-000277","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000277/edgar.xml","form_type":"4"}},{"id":4226470,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-08-23T16:51:38.000Z","date":"2017-08-22","kind":"purchase","acquired":true,"shares":2000,"price":0.25,"value":500.0,"ownership":{"direct":false,"nature":"By UTMA #2"},"balance_after":51166,"source":{"system":"sec-edgar","filing":"0000914190-17-000259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000259/edgar.xml","form_type":"4"}},{"id":4226469,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-08-23T16:51:38.000Z","date":"2017-08-22","kind":"purchase","acquired":true,"shares":2000,"price":0.25,"value":500.0,"ownership":{"direct":false,"nature":"By UTMA #1"},"balance_after":53666,"source":{"system":"sec-edgar","filing":"0000914190-17-000259","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000259/edgar.xml","form_type":"4"}},{"id":4236489,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-08-11T21:35:42.000Z","date":"2017-08-11","kind":"purchase","acquired":true,"shares":70000,"price":0.26,"value":18200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.2545 to $0.2771 inclusive. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,165 shares of restricted stock that vest on June 14, 2017, 213,068 shares of restricted stock that vest on June 23, 2017 and 17,756 shares of restricted stock that vest on September 30, 2017."}],"balance_after":683378,"source":{"system":"sec-edgar","filing":"0000914190-17-000236","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000236/edgar.xml","form_type":"4"}},{"id":4283524,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-13T20:19:31.000Z","date":"2017-06-09","kind":"purchase","acquired":true,"shares":7500,"price":0.26,"value":1950.0,"ownership":{"direct":false,"nature":"By UTMA #2"},"balance_after":49166,"source":{"system":"sec-edgar","filing":"0000914190-17-000167","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000167/edgar.xml","form_type":"4"}},{"id":4283523,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-13T20:19:31.000Z","date":"2017-06-09","kind":"purchase","acquired":true,"shares":10000,"price":0.26,"value":2600.0,"ownership":{"direct":false,"nature":"By UTMA #1"},"balance_after":51666,"source":{"system":"sec-edgar","filing":"0000914190-17-000167","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000167/edgar.xml","form_type":"4"}},{"id":4283522,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-06-13T20:19:31.000Z","date":"2017-06-12","kind":"purchase","acquired":true,"shares":3961,"price":0.26,"value":1029.86,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,165 shares of restricted stock that vest on June 14, 2017, 213,068 shares of restricted stock that vest on June 23, 2017 and 17,756 shares of restricted stock that vest on September 30, 2017."}],"balance_after":613378,"source":{"system":"sec-edgar","filing":"0000914190-17-000167","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000167/edgar.xml","form_type":"4"}},{"id":4311596,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-05-19T21:55:03.000Z","date":"2017-05-19","kind":"purchase","acquired":true,"shares":7500,"price":0.255,"value":1912.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,165 shares of restricted stock that vest on June 14, 2017, 213,068 shares of restricted stock that vest on June 23, 2017 and 17,756 shares of restricted stock that vest on September 30, 2017."}],"balance_after":609417,"source":{"system":"sec-edgar","filing":"0000914190-17-000160","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000160/edgar.xml","form_type":"4"}},{"id":4311595,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-05-19T21:55:03.000Z","date":"2017-05-18","kind":"purchase","acquired":true,"shares":22500,"price":0.255,"value":5737.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 9,165 shares of restricted stock that vest on June 14, 2017, 213,068 shares of restricted stock that vest on June 23, 2017 and 17,756 shares of restricted stock that vest on September 30, 2017."}],"balance_after":601917,"source":{"system":"sec-edgar","filing":"0000914190-17-000160","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000160/edgar.xml","form_type":"4"}},{"id":4360764,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-04-04T20:49:21.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":17756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 31, 2017, the Company granted 17,756 shares of restricted stock (the \"Restricted Stock\") to the Reporting Person in satisfaction of previously-deferred base salary. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,165 shares of restricted stock that vest on June 14, 2017, 213,068 shares of restricted stock that vest on June 23, 2017 and 17,756 shares of restricted stock that vest on September 30, 2017."}],"balance_after":579417,"source":{"system":"sec-edgar","filing":"0000914190-17-000117","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000117/edgar.xml","form_type":"4"}},{"id":4376367,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock Warrants (Right to Buy)","published_at":"2017-03-21T21:52:35.000Z","date":"2017-03-17","kind":"purchase","acquired":true,"shares":41666,"ownership":{"direct":false,"nature":"By UTMA #2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities have a purchase price of $0.30 per share of Common Stock. In addition, the reporting person indirectly received a Warrant to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock otherwise purchased. The reporting person indirectly purchased 41,666 shares of Common Stock and was indirectly issued a related Warrant to acquire up to 41,666 shares of Common Stock."}],"balance_after":41666,"derivative":{"exercise_price":0.3,"exercise_date":"2017-03-17","expiration_date":"2022-03-17","underlying":"Common Stock","underlying_shares":41666},"source":{"system":"sec-edgar","filing":"0000914190-17-000112","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000112/edgar.xml","form_type":"4"}},{"id":4376366,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock Warrants (Right to Buy)","published_at":"2017-03-21T21:52:35.000Z","date":"2017-03-17","kind":"purchase","acquired":true,"shares":41666,"ownership":{"direct":false,"nature":"By UTMA #1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities have a purchase price of $0.30 per share of Common Stock. In addition, the reporting person indirectly received a Warrant to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock otherwise purchased. The reporting person indirectly purchased 41,666 shares of Common Stock and was indirectly issued a related Warrant to acquire up to 41,666 shares of Common Stock."}],"balance_after":41666,"derivative":{"exercise_price":0.3,"exercise_date":"2017-03-17","expiration_date":"2022-03-17","underlying":"Common Stock","underlying_shares":41666},"source":{"system":"sec-edgar","filing":"0000914190-17-000112","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000112/edgar.xml","form_type":"4"}},{"id":4376365,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-03-21T21:52:35.000Z","date":"2017-03-17","kind":"purchase","acquired":true,"shares":41666,"ownership":{"direct":false,"nature":"By UTMA #2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities have a purchase price of $0.30 per share of Common Stock. In addition, the reporting person indirectly received a Warrant to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock otherwise purchased. The reporting person indirectly purchased 41,666 shares of Common Stock and was indirectly issued a related Warrant to acquire up to 41,666 shares of Common Stock."}],"balance_after":41666,"source":{"system":"sec-edgar","filing":"0000914190-17-000112","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000112/edgar.xml","form_type":"4"}},{"id":4376364,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-03-21T21:52:35.000Z","date":"2017-03-17","kind":"purchase","acquired":true,"shares":41666,"ownership":{"direct":false,"nature":"By UTMA #1"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities have a purchase price of $0.30 per share of Common Stock. In addition, the reporting person indirectly received a Warrant to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock otherwise purchased. The reporting person indirectly purchased 41,666 shares of Common Stock and was indirectly issued a related Warrant to acquire up to 41,666 shares of Common Stock."}],"balance_after":41666,"source":{"system":"sec-edgar","filing":"0000914190-17-000112","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419017000112/edgar.xml","form_type":"4"}},{"id":4512391,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-12-23T21:44:25.000Z","date":"2016-12-23","kind":"grant","acquired":true,"shares":213068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 23, 2016, the Company granted 213,068 shares of restricted stock (the \"Restricted Stock\") to the Reporting Person in lieu of a $60,000 cash bonus. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date."}],"balance_after":561661,"source":{"system":"sec-edgar","filing":"0000914190-16-000993","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419016000993/edgar.xml","form_type":"4"}},{"id":4520457,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-12-15T21:33:22.000Z","date":"2016-12-14","kind":"grant","acquired":true,"shares":9165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 14, 2016, the Company granted 9,165 shares of restricted stock (the \"Restricted Stock\") to the Reporting Person in satisfaction of previously-deferred base salary. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests six months following the grant date."}],"balance_after":348593,"source":{"system":"sec-edgar","filing":"0000914190-16-000989","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419016000989/edgar.xml","form_type":"4"}},{"id":4527008,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-12-09T22:11:51.000Z","date":"2016-12-07","kind":"purchase","acquired":true,"shares":4069,"price":0.32,"value":1302.08,"ownership":{"direct":true},"balance_after":339428,"source":{"system":"sec-edgar","filing":"0000914190-16-000930","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419016000930/edgar.xml","form_type":"4"}},{"id":4531213,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-12-06T21:37:58.000Z","date":"2016-12-05","kind":"purchase","acquired":true,"shares":6020,"price":0.34,"value":2046.8,"ownership":{"direct":true},"balance_after":335359,"source":{"system":"sec-edgar","filing":"0000914190-16-000921","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419016000921/edgar.xml","form_type":"4"}},{"id":4531212,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-12-06T21:37:58.000Z","date":"2016-12-05","kind":"purchase","acquired":true,"shares":4600,"price":0.3399,"value":1563.54,"ownership":{"direct":true},"balance_after":329339,"source":{"system":"sec-edgar","filing":"0000914190-16-000921","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419016000921/edgar.xml","form_type":"4"}},{"id":4535171,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-12-02T21:28:17.000Z","date":"2016-12-01","kind":"purchase","acquired":true,"shares":40599,"price":0.3206,"value":13016.0394,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $0.315 to $0.33 inclusive.  The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":324739,"source":{"system":"sec-edgar","filing":"0000914190-16-000918","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419016000918/edgar.xml","form_type":"4"}},{"id":4535170,"issuer":{"id":7279,"kind":"organization","name":"NEPHROS INC","symbol":"NEPH"},"owners":[{"id":31669,"kind":"person","name":"Evans Daron","position":1,"cik":"0001411726","reported_name":"Evans Daron","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-12-02T21:28:17.000Z","date":"2016-11-30","kind":"purchase","acquired":true,"shares":931,"price":0.29,"value":269.99,"ownership":{"direct":true},"balance_after":284140,"source":{"system":"sec-edgar","filing":"0000914190-16-000918","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411726/000091419016000918/edgar.xml","form_type":"4"}}]}